tiprankstipranks
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC
US Market

Cyclacel Pharmaceuticals (CYCC) Technical Analysis

Compare
692 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Cyclacel Pharmaceuticals’s (CYCC) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Cyclacel Pharmaceuticals is a Sell.
Cyclacel Pharmaceuticals’s (CYCC) 20-Day exponential moving average is 0.35, while Cyclacel Pharmaceuticals’s (CYCC) share price is $0.34, making it a Sell.
Cyclacel Pharmaceuticals’s (CYCC) 50-Day exponential moving average is 0.39, while Cyclacel Pharmaceuticals’s (CYCC) share price is $0.34, making it a Sell.

Cyclacel Pharmaceuticals (CYCC) Pivot Points

Feb 22, 2025, 10:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.32
0.33
0.34
0.35
0.36
0.37
0.38
Fibonacci
0.33
0.34
0.34
0.35
0.36
0.36
0.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cyclacel Pharmaceuticals (CYCC) Moving Averages

Feb 22, 2025, 10:37 AM
Period
Simple
Exponential
MA5
0.35Sell
0.34Sell
MA10
0.34Buy
0.34Sell
MA20
0.34Sell
0.35Sell
MA50
0.36Sell
0.39Sell
MA100
0.51Sell
0.57Sell
MA200
1.06Sell
1.06Sell
Cyclacel Pharmaceuticals’s (CYCC) 10-Day exponential moving average is 0.34, while Cyclacel Pharmaceuticals’s (CYCC) share price is $0.34, making it a Sell.
Cyclacel Pharmaceuticals’s (CYCC) 100-Day exponential moving average is 0.57, while Cyclacel Pharmaceuticals’s (CYCC) share price is $0.34, making it a Sell.
Cyclacel Pharmaceuticals’s (CYCC) stock price is $0.34 and Cyclacel Pharmaceuticals’s (CYCC) 50-day simple moving average is 0.36, creating a Sell signal.
Cyclacel Pharmaceuticals’s (CYCC) stock price is $0.34 and Cyclacel Pharmaceuticals’s (CYCC) 100-day simple moving average is 0.51, creating a Sell signal.
Cyclacel Pharmaceuticals’s (CYCC) stock price is $0.34 and Cyclacel Pharmaceuticals’s (CYCC) 200-day simple moving average is 1.06, creating a Sell signal.

Cyclacel Pharmaceuticals (CYCC) Technical Indicators

Feb 22, 2025, 10:37 AM
Name
Value
Implied Action
RSI (14)
46.61
Neutral
STOCH (9,6)
57.81
Neutral
STOCHRSI (14)
57.81
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
23.48
Neutral
Williams %R
-50.63
Buy
CCI (14)
-8.16
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
57.68
Neutral
ROC
3.03
Buy
Cyclacel Pharmaceuticals’s (CYCC) Relative Strength Index (RSI) is 46.61, creating a Neutral signal.
Cyclacel Pharmaceuticals’s (CYCC) Trend Strength Indicator (ADX) is 23.48, creating a Neutral signal.
Cyclacel Pharmaceuticals’s (CYCC) Commodity Channel Index (CCI) is -8.16, creating a Neutral signal.
Cyclacel Pharmaceuticals’s (CYCC) Price Rate of Change (ROC) is 3.03, creating a Buy signal.

FAQ

Is CYCC a Buy, Hold, or Sell?
Based on CYCC’s technical indicators, CYCC is a Sell.
    What is CYCC’s RSI (14)?
    CYCC’s RSI (14) is 46.61, which suggests CYCC is a Neutral.
      What is CYCC’s MACD?
      CYCC’s MACD is >-0.01, which suggests CYCC is a Sell.
        What is CYCC’s 5-day moving average?
        CYCC’s 5-day moving average is 0.35, which suggests CYCC is a Sell.
          What is CYCC’s 20-day moving average?
          CYCC 20-day moving average is 0.34, which suggests CYCC is a Sell.
            What is CYCC’s 50-day moving average?
            CYCC’s 50-day moving average is 0.36, which suggests CYCC is a Sell.
              What is CYCC’s 200-day moving average?
              CYCC’s 200-day moving average is 1.06, which suggests CYCC is a Sell.
                What is CYCC’s Williams % R (14)?
                CYCC’s Williams % R (14) is -50.63, which suggests CYCC is a Buy.
                  What is CYCC’s CCI (14)?
                  CYCC’s CCI (14) is -8.16, which suggests CYCC is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis